EUBREAST 05 (R) SerMa (Seroma of the Mammary Gland)

SERMA (Seroma of the Mammary gland)
Below please find

SerMa (Seroma of the Mammary Gland)

  • PI: Prof. Dr. Nina Ditsch
  • Study supported by EUBREAST
  • Trial design: Trial design: Prospective, interventional, multicenter non-AMG/MPG study to detect possible markers for prediction and risk assessment of a breast seroma after skin-sparing mastectomy and implant breast reconstruction
  • Primary endpoint: Discovery of immune markers for risk assessment of developing a seroma, analysis of the microbiome diversity and differentiation between a specific immune reaction and a general infection in development of a seroma.

Study expected to start in Q1 2024

Become a member to stay updated!
The Benefits of EUBREAST Membership
Enter into a network of renowned international breast surgeons
Access to detailed information on ongoing and previous projects and events
Take part in international cross-border studies
Publish your EUBREAST membership status on your website / social media platforms together with the respective logo.